Abstract
BackgroundPhysical identical and pharmacological inert are the basic requirements for placebo design, which are essential in clinical trials to evaluate the efficacy of an intervention. However, it is difficult to makeup a placebo of Chinese herbal medicine (CHM) because of special color, taste and smell, etc. Currently, there is no specific requirements and standards for the creation of a CHM-placebo. The purpose of this study is to review the characteristics of the CHM-placebo design and application in registered clinical trials with CHM interventions and identify the common problems, if any.MethodsThe World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) was systematically searched for CHM interventional trials with placebo-controlled design up to 31 December 2017. Registered information of each included trial was collected from specific registries involved in ICTRP through hyperlinks. Descriptive statistics were used to analyze the characteristics of placebo design in CHM trial registrations.ResultsA total of 889 CHM interventional trials were registered from 1999 to 2017, and 40.8% (363) of them included CHM-placebo control design. The common ways of their design were: placebo as sole control (191, 52.6%); placebo as add-on control with baseline treatment (84, 23.1%); and placebo as double-dummy control (57, 15.7%). Among 363 included trials, 46 (12.7%) reported the compositions of placebos, including CHM ingredients (17 trials), excipients and other agents (29 trials). 2 (0.6%) reported pharmacological inert testing, and 52 (14.3%) descripted their placebos to be physically identical with the CHMs. 14 (3.9%) reported quality control of placebos, and 2 (0.6%) provided blinding assessment of placebos.ConclusionsThe placebos included in most CHM trial registrations is not optimal in terms of placebo design, application, evaluation and reporting. Specific guidelines or standards of CHM-placebo design, including usage requirements, preparation specifications, quality assessments and reporting guidelines should be developed thus to improve their quality.
Highlights
Physical identical and pharmacological inert are the basic requirements for placebo design, which are essential in clinical trials to evaluate the efficacy of an intervention
This study aimed to review the overall characteristics of placebo design and application in Chinese herbal medicine (CHM) clinical trial registrations
Study design and setting The World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) was searched for registered CHM clinical trials with placebo-controlled design up to 31 December 2017 in this study, and descriptive statistics were used to analyze their characteristics of placebo design
Summary
Physical identical and pharmacological inert are the basic requirements for placebo design, which are essential in clinical trials to evaluate the efficacy of an intervention. It is difficult to makeup a placebo of Chinese herbal medicine (CHM) because of special color, taste and smell, etc. For many CHM clinical trials, creating a quality placebo is extraordinarily difficult because the herbs often have special colors, tastes and smells [3]. The word “placebo” originates from Latin; it means “I shall please”. It was first used in the 14th century, but did not appear in a documented medical record until the late 18th century [4]. The term “placebo” refers to a harmless pill, medicine, or procedure with no therapeutic effect; it is used in two contexts: (a) prescribed to patients for psychological benefit; or (b) used in clinical trials as a way to test the efficacy of new drugs [5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
